• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带常见突变的T细胞淋巴瘤、B细胞淋巴瘤和骨髓增生异常综合征:源自共同始祖克隆的三系肿瘤发生。

T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone.

作者信息

Yoshihara Kyoko, Nannya Yasuhito, Matsuda Ikuo, Samori Mami, Utsunomiya Nobuto, Okada Masaya, Hirota Seiichi, Ogawa Seishi, Yoshihara Satoshi

机构信息

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.

Department of Pathology and Tumor Biology Kyoto University Kyoto Japan.

出版信息

EJHaem. 2021 Dec 3;3(1):211-214. doi: 10.1002/jha2.354. eCollection 2022 Feb.

DOI:10.1002/jha2.354
PMID:35846192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175790/
Abstract

A 64-year-old man with angioimmunoblastic T-cell lymphoma (AITL) subsequently developed diffuse large B-cell lymphoma (DLBCL) and myelodysplastic syndrome (MDS). Genomic profiling of AITL, DLBCL, and MDS samples revealed that the tumor cells from all samples shared common mutations in and . In addition, the mutation was observed in AITL, and mutation was observed in DLBCL and MDS. These findings illustrate the clonal relationship between AITL and DLBCL in addition to AITL and MDS, with the latter being increasingly reported. The present findings strongly support the theory of multistep and multilineage tumorigenesis from a common founder clone.

摘要

一名64岁患有血管免疫母细胞性T细胞淋巴瘤(AITL)的男性患者随后发展为弥漫性大B细胞淋巴瘤(DLBCL)和骨髓增生异常综合征(MDS)。对AITL、DLBCL和MDS样本进行的基因组分析显示,所有样本中的肿瘤细胞在 和 中存在共同突变。此外,在AITL中观察到 突变,在DLBCL和MDS中观察到 突变。这些发现说明了AITL与DLBCL之间以及AITL与MDS之间的克隆关系,后者的报道日益增多。目前的研究结果有力地支持了从一个共同的始祖克隆发生多步骤和多谱系肿瘤发生的理论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b86/9175790/a3d7a6557396/JHA2-3-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b86/9175790/efdecbf82b3a/JHA2-3-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b86/9175790/a3d7a6557396/JHA2-3-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b86/9175790/efdecbf82b3a/JHA2-3-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b86/9175790/a3d7a6557396/JHA2-3-211-g001.jpg

相似文献

1
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone.携带常见突变的T细胞淋巴瘤、B细胞淋巴瘤和骨髓增生异常综合征:源自共同始祖克隆的三系肿瘤发生。
EJHaem. 2021 Dec 3;3(1):211-214. doi: 10.1002/jha2.354. eCollection 2022 Feb.
2
Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.克隆性造血与骨髓浸润在生发中心 B 细胞型滤泡辅助性 T 细胞淋巴瘤患者中的临床意义
Mod Pathol. 2024 Jul;37(7):100519. doi: 10.1016/j.modpat.2024.100519. Epub 2024 May 21.
3
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor.通过流式细胞术分选进行的分子遗传学分析鉴定出血管免疫母细胞性T细胞淋巴瘤和源自同一造血祖细胞的伴发骨髓增生异常综合征。
J Hematol. 2020 Dec;9(4):140-146. doi: 10.14740/jh760. Epub 2020 Nov 6.
4
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.突变分析将血管免疫母细胞 T 细胞淋巴瘤与克隆性造血和吸烟联系起来。
Elife. 2021 Sep 29;10:e66395. doi: 10.7554/eLife.66395.
5
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.IDH2 和 TET2 突变协同调节滤泡辅助性 T 细胞与 AITL 微环境的功能相互作用。
Cancer Cell. 2023 Feb 13;41(2):323-339.e10. doi: 10.1016/j.ccell.2023.01.003. Epub 2023 Feb 2.
6
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.克隆性造血中两种不同淋巴样增殖的平行进化。
Histopathology. 2022 Apr;80(5):847-858. doi: 10.1111/his.14619. Epub 2022 Mar 1.
7
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.血管免疫母细胞性 T 细胞淋巴瘤中 RHOA 突变的临床病理意义:一项荟萃分析:AITL 中的 RHOA 突变。
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):431-438. doi: 10.1016/j.clml.2021.03.002. Epub 2021 Mar 19.
8
Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.弥漫性大B细胞淋巴瘤治疗后发生血管免疫母细胞性T细胞淋巴瘤:一例报告并文献复习
Int J Clin Exp Pathol. 2014 May 15;7(6):3432-8. eCollection 2014.
9
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.血管免疫母细胞性 T 细胞淋巴瘤包含多个克隆 T 细胞群体,这些细胞来源于一个共同的 TET2 突变祖细胞。
J Pathol. 2020 Mar;250(3):346-357. doi: 10.1002/path.5376. Epub 2020 Jan 16.
10
TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.血管免疫母细胞性T细胞淋巴瘤患者B细胞中的TET2突变
J Pathol. 2017 Jun;242(2):129-133. doi: 10.1002/path.4898. Epub 2017 May 3.

引用本文的文献

1
Complex Interplay Between Sweet Syndrome and Therapy-Related Myelodysplastic Syndrome After B-Cell Lymphoma Treatment: A Case Report.B细胞淋巴瘤治疗后Sweet综合征与治疗相关的骨髓增生异常综合征之间的复杂相互作用:一例报告
Am J Case Rep. 2025 Aug 11;26:e949165. doi: 10.12659/AJCR.949165.
2
Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.循环肿瘤DNA是血管免疫母细胞性T细胞淋巴瘤反应的生物标志物。
Int J Mol Sci. 2025 Jul 13;26(14):6719. doi: 10.3390/ijms26146719.
3
Temporal clonal relatedness between myeloid neoplasm and nodal T-follicular helper cell lymphoma: a retrospective study.

本文引用的文献

1
New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.血管免疫母细胞性T细胞淋巴瘤的新临床前模型:填补空白。
Oncogenesis. 2020 Aug 14;9(8):73. doi: 10.1038/s41389-020-00259-x.
2
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.TP53 等位基因状态对骨髓增生异常综合征的基因组稳定性、临床表现和预后的影响。
Nat Med. 2020 Oct;26(10):1549-1556. doi: 10.1038/s41591-020-1008-z. Epub 2020 Aug 3.
3
Advances in understanding of angioimmunoblastic T-cell lymphoma.
髓系肿瘤与结内T滤泡辅助细胞淋巴瘤之间的时间克隆相关性:一项回顾性研究。
Blood Neoplasia. 2025 May 11;2(3):100112. doi: 10.1016/j.bneo.2025.100112. eCollection 2025 Aug.
4
Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera.同一患者中三种不同造血肿瘤的共同克隆起源:B 细胞淋巴瘤、T 细胞淋巴瘤和真性红细胞增多症。
Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4). doi: 10.1101/mcs.a006313. Print 2023 Dec.
5
Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells.一名患者三种血液系统恶性肿瘤的多组学研究揭示了它们起源于克隆性造血干细胞。
Blood Cancer J. 2023 Aug 9;13(1):118. doi: 10.1038/s41408-023-00892-w.
对血管免疫母细胞性 T 细胞淋巴瘤的认识进展。
Leukemia. 2020 Oct;34(10):2592-2606. doi: 10.1038/s41375-020-0990-y. Epub 2020 Jul 23.
4
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.血管免疫母细胞性 T 细胞淋巴瘤中克隆性造血与向髓系肿瘤分化的演进。
Blood Adv. 2020 May 26;4(10):2261-2271. doi: 10.1182/bloodadvances.2020001636.
5
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in , and - azacitidine induces only lymphoma remission.血管免疫母细胞性T细胞淋巴瘤和伴有 、 和 基因突变的骨髓增生异常综合征——阿扎胞苷仅诱导淋巴瘤缓解。
Leuk Lymphoma. 2019 Dec;60(13):3316-3319. doi: 10.1080/10428194.2019.1627541. Epub 2019 Jun 17.
6
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.外周 T 细胞淋巴瘤分子亚群中致癌途径的遗传驱动因素。
Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.
7
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.高危克隆性造血作为血管免疫母细胞性T细胞淋巴瘤和NPM1突变型急性髓系白血病的起源
N Engl J Med. 2018 Sep 6;379(10):981-984. doi: 10.1056/NEJMc1806413.
8
Identification of cell-type-specific mutations in nodal T-cell lymphomas.结外T细胞淋巴瘤中细胞类型特异性突变的鉴定。
Blood Cancer J. 2017 Jan 6;7(1):e516. doi: 10.1038/bcj.2016.122.
9
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.一名先患EBV阳性大B细胞淋巴瘤,后患TET2突变型血管免疫母细胞性T细胞淋巴瘤和慢性粒单核细胞白血病的患者对5-氮杂胞苷的反应。
Hematol Oncol. 2017 Dec;35(4):864-868. doi: 10.1002/hon.2319. Epub 2016 Jun 29.
10
Roles of IDH1/2 and TET2 mutations in myeloid disorders.异柠檬酸脱氢酶1/2(IDH1/2)和四氢叶酸还原酶2(TET2)突变在髓系疾病中的作用。
Int J Hematol. 2016 Jun;103(6):627-33. doi: 10.1007/s12185-016-1973-7. Epub 2016 Mar 15.